NCT06373809View on ClinicalTrials.gov

Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Diabetic FootDiabetic NeuropathiesDiabetic Foot Ulcer
Interventions
BIOLOGICAL

Transplantation of Placenta Derived Stem Cells

Subcutaneously administered placental-derived SVF / PDSC cells in foot, ankle, and calf tissues in 20 DFU patients

Trial Locations (2)

21000

Hospital Escuela Oscar Danilo Rosales Arguello (HEODRA), León

61000

Hospital Escuela Cesar Amador Molina, Matagalpa

All Listed Sponsors
collaborator

Ministerio de Salud de Nicaragua

UNKNOWN

collaborator

Wake Forest Institute for Regenerative Medicine

UNKNOWN

lead

Michael H Carstens

OTHER

NCT06373809 - Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy | Biotech Hunter | Biotech Hunter